Answer to the comment of Hai Lu et al. regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)".
Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128, Mainz, Germany. efferth@uni-mainz.de.
Thomas
T
Efferth
Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128, Mainz, Germany.
Ursula
U
Schöttler
Institute for Infection and Immunity, St. George's, University of London, London, UK.
Sanjeev
S
Krishna
Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
Peter
P
Schmiedek
Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
Frederik
F
Wenz
Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
Frank A
FA
Giordano
D037621:Artemisinins; D000077332:Artesunate; D001932:Brain Neoplasms; D056486:Chemical and Drug Induced Liver Injury; D003606:Dacarbazine / Q000031:analogs & derivatives; D005909:Glioblastoma; D006801:Humans; D000077204:Temozolomide
D037621:Artemisinins; D000077332:Artesunate; D003606:Dacarbazine; D000077204:Temozolomide